“…Head and neck cancer, which includes cancers of the larynx, throat, lips, mouth, nose, and salivary glands, is now an epidemic with 65,000 new cases in the US annually [1], whose treatment is, as in many other types of cancers, a dynamic and complex process. This therapy process involves making multiple, patient-specific treatment decisions, to maximize efficacy---e.g., reduction in tumor size, time of local region control, and survival time, while minimizing side effects [2,3,4]. For example, a specific patient may undergo radiotherapy alone (RT), radiotherapy with concurrent chemotherapy (CC), or induction chemotherapy (IC) [5].…”